Project Oncology® CME
Project Oncology® CME presents a wide array of oncology CME topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. The series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes. Each program is designed to be a short, easy-to-digest format of 15 to 30 minutes.
Episodes 1-15 of 27
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®Reviewing the Latest Bladder Cancer Practice Guidelines
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
Diversity in HER2 Expression Among Gynecologic Cancers
MinuteCE®Diversity in HER2 Expression Among Gynecologic Cancers
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
MinuteCE®HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
MinuteCE®Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
MinuteCE®Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Significance of HER2 Expression in Solid Tumors
MinuteCE®Significance of HER2 Expression in Solid Tumors
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
MinuteCE®Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
MinuteCE®Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
MinuteCE®Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
WHIM Syndrome Management: The First FDA Approval for Patients
MinuteCE®WHIM Syndrome Management: The First FDA Approval for Patients
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
MinuteCE®You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
